Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 1
2004 2
2005 2
2006 4
2007 7
2008 2
2009 2
2010 6
2011 4
2012 6
2013 5
2014 1
2015 2
2016 1
2017 2
2018 2
2019 1
2020 7
2021 3
2022 8
2023 4
2024 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Noninvertible Time-Reversal Symmetry.
Choi Y, Lam HT, Shao SH. Choi Y, et al. Among authors: shao sh. Phys Rev Lett. 2023 Mar 31;130(13):131602. doi: 10.1103/PhysRevLett.130.131602. Phys Rev Lett. 2023. PMID: 37067311
[Ferroptosis:Mechanisms and Application in Tumor Treatment].
Shao SH, Qiu ST, Li Y, Zhang YY, Cao YJ, DI CH, Tan XH. Shao SH, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024 Oct;46(5):732-739. doi: 10.3881/j.issn.1000-503X.15881. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024. PMID: 39502055 Free article. Review. Chinese.
Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial.
Lenz HJ, Parikh A, Spigel DR, Cohn AL, Yoshino T, Kochenderfer M, Elez E, Shao SH, Deming D, Holdridge R, Larson T, Chen E, Mahipal A, Ucar A, Cullen D, Baskin-Bey E, Kang T, Hammell AB, Yao J, Tabernero J. Lenz HJ, et al. Among authors: shao sh. J Immunother Cancer. 2024 Mar 13;12(3):e008409. doi: 10.1136/jitc-2023-008409. J Immunother Cancer. 2024. PMID: 38485190 Free PMC article. Clinical Trial.
Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma.
Fowler NH, Samaniego F, Jurczak W, Ghosh N, Derenzini E, Reeves JA, Knopińska-Posłuszny W, Cheah CY, Phillips T, Lech-Maranda E, Cheson BD, Caimi PF, Grosicki S, Leslie LA, Chavez JC, Fonseca G, Babu S, Hodson DJ, Shao SH, Burke JM, Sharman JP, Law JY, Pagel JM, Miskin HP, Sportelli P, O'Connor OA, Weiss MS, Zinzani PL. Fowler NH, et al. Among authors: shao sh. J Clin Oncol. 2021 May 20;39(15):1609-1618. doi: 10.1200/JCO.20.03433. Epub 2021 Mar 8. J Clin Oncol. 2021. PMID: 33683917 Free PMC article. Clinical Trial.
76 results